You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
The Institutional Review Board and beyond: Future Challenges to the Ethics of Human Experimentation
Harold Edgar and David J. Rothman
The Milbank Quarterly
Vol. 73, No. 4 (1995), pp. 489-506
Stable URL: http://www.jstor.org/stable/3350283
Page Count: 18
You can always find the topics here!Topics: Institutional review boards, Research ethics, Human experimentation, Ethics committees, Research grants, Funding, Drug regulation, Medical research, Political ethics, Grants
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Over the past two decades, institutional review boards (IRBs) have transformed the conduct of clinical research, in the process protecting human subjects and setting an admirable standard for monitoring the ethics of science. Nevertheless, the very proliferation of these committees, in addition to changing the character and sponsorship of new research, suggests that a "one size fits all" approach to the governance of human experimentation may have outlived its usefulness. It may be time to remove the "I" from the IRB and create a system with greater national oversight. Whether such a change can be accomplished within the current political climate is debatable. But the need for such a shift is becoming increasingly apparent.
The Milbank Quarterly © 1995 Milbank Memorial Fund